BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Rubicon Research Limited

-

Offer Period :

Rubicon Research, a specialty pharmaceutical company based in Mumbai, develops various dosage forms and received a $100 million investment from General Atlantic in 2019. Read more...It operates out of locations in Thane, Ambernath, Concord, and Plainsboro, focusing on formulation development and manufacturing.Read less

Rubicon Research Limited IPO Details

IPO Date - Minimum Investment ₹ / Lots
Listing Date Maximum Investment ₹ / Lots
Face Value ₹0 per share Total Issue Size ₹0 Crores
Price ₹0 to ₹0 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (0 Shares) Offer For Sale ₹ 0
Listing At Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date -
Listing Date
Face Value ₹0 per share
Price ₹0 to ₹0 per share
Lot Size 1 Lots (0 Shares)
Listing At
Employee Discount ₹0 per share
Minimum Investment ₹ / Lots
Maximum Investment ₹ / Lots
Total Issue Size ₹0 Crores
Fresh Issue ₹0 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

-

IPO Starts

-

IPO Ends

-

Allotment Date

-

Initiation of Refund

-

Credit of Shares to Demat Account

-

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0 0
Public Group 0 0

Rubicon Research Limited IPO Reservation

QIB Shares Offered 0(0%)
NII (HNI) Shares Offered 0(0%)
Retail Shares Offered 0(0%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Rubicon Research Limited IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 81081 14949
Email Id rubicon.ipo @linkintime.co.in
Our Website www.linkintime.co.in

Rubicon Research Limited IPO Lead Manager

1. Axis Capital Ltd

2. IIFL Securities Ltd

3. JM Financial Ltd

4. SBI Capital Markets Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Rubicon Research Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Rubicon Research Limited

1. We are the fastest growing Indian pharmaceutical company amongst our peers and the only Indian company focused completely on the US market.

2. Our data-driven product selection framework has allowed us to build a product portfolio with a combination of new and specialty products allowing us to withstand pricing pressures.

3. Our R&D capabilities and continuing investment allow us to pursue complex products that offer strong revenue opportunities.

4. Robust sales and distribution capabilities in the US.

5. Strong track record of compliance combined with expertise in cost effective manufacturing

6. Experienced and entrepreneurial management team with a proven track record and marquee private equity investor.

Risks Involved

1. As on March 31, 2024, we derive ?8,317.14 million and 97.40% of our revenue from operations from the United States and any adverse developments in the United States could have an adverse effect on our business and results of operations.

2. As the manufacture of our products is technically complex and highly regulated, product recalls, regulatory inspection failures or shortcomings at our manufacturing facilities or other problems may reduce sales, adversely affect our business, financial condition and results of operations and delay the launch of new products, and in some cases may lead to closures of our facilities.

3. We have a history of net losses, negative earnings per share ("EPS") and return on capital employed. We need to generate and sustain increased revenues while managing our expenses to achieve profitability, and our inability to achieve these goals may have an adverse effect on our business, results of operations, cash flows and financial condition.

4. In Fiscals 2024, 2023 and 2022, we derived 65.14%, 62.99% and 92.44%, respectively, of our revenue from sale of goods from our top five customers and the loss of one or more such customers could adversely affect our business and prospects.

5. We expect to spend a significant amount of resources on research and development efforts. Such efforts may not result in marketable products. Failure to successfully introduce products into the market could have a material adverse effect on our business, financial condition, and results of operations.

6. Any disruption, breakdown or shutdown of our research and development and manufacturing facilities may have a material adverse effect on our business, financial condition, results of operations and cash flows.

7. Our Company is involved in certain legal proceedings. Any adverse decision in such proceedings may render us/them liable to liabilities/penalties and may adversely affect our business, financial condition, results of operations and cash flows.

8. Our success depends on our ability to execute our growth strategies. If we are unable to sustain or manage our growth, our business, results of operations, cash flows and financial condition may be adversely affected.

9. We face significant competitive pressures in our business from other pharmaceutical manufacturers. Our inability to compete effectively would be detrimental to our business and prospects for future growth.

10. The market in which we operate is subject to consolidation and disruption, and our inability to navigate such changes could adversely affect our business, financial condition and results of operation.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 1109.49 749.7 559.52
Total Liabilities 1109.49 749.7 559.52
Total Expenses 769.53 430.05 396.53
Total Revenue 
872.39 419 330.42
Profit After Tax 91.01 -16.89 -67.12
EBITDA 173.09 43.97 -22.38
Adjusted EBITDA 0 0 0

Rubicon Research Limited IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
0 -
INE506V01022
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹0 ₹0
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

Frequently Asked Questions

What is Rubicon Research Limited IPO?

Answer Field

Rubicon Research Limited IPO is a [-] IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on [-].

When Rubicon Research Limited IPO will open?

Answer Field

The Rubicon Research Limited IPO opens on [-] and closes on [-].

What is the lot size of Rubicon Research Limited?

Answer Field

Rubicon Research Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Rubicon Research Limited IPO?

Answer Field

You can apply in Rubicon Research Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Rubicon Research Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Rubicon Research Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Rubicon Research Limited IPO listing date?

Answer Field

The Rubicon Research Limited listing date is [-].

Who is the registrar of Rubicon Research Limited IPO?

Answer Field

The registrar of Rubicon Research Limited IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Axis Capital Ltd,IIFL Securities Ltd,JM Financial Ltd,SBI Capital Markets Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Rubicon Research Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Rubicon Research Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Rubicon Research Limited IPO?

Answer Field

To apply for Rubicon Research Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Rubicon Research Limited?

Answer Field

The price of each Rubicon Research Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Rubicon Research Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • TOSS THE COIN LIMITEDSME IPO

  • Bidding Dates

    10th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹172.0 - 182.0

  • IPO Size

    ₹9,17,00,000

  • Apply Now
  • JUNGLE CAMPS INDIA LIMITEDSME IPO

  • Bidding Dates

    10th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹68.0 - 72.0

  • IPO Size

    ₹29,42,00,000

  • Apply Now
  • ONE MOBIKWIK SYSTEMS LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹265.0 - 279.0

  • IPO Size

    ₹5,72,00,00,000

  • Apply Now
  • PURPLE UNITED SALES LIMITEDSME IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹121.0 - 126.0

  • IPO Size

    ₹32,81,00,000

  • Apply Now
  • SAI LIFE SCIENCES LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹522.0 - 549.0

  • IPO Size

    ₹30,42,62,00,000

  • Apply Now
  • VISHAL MEGA MART LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹74.0 - 78.0

  • IPO Size

    ₹80,00,00,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text